Last updated on November 2017

ANBL12P1: Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma


Brief description of study

ANBL12P1: Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients With Newly Diagnosed High-Risk Neuroblastoma

Detailed Study Description

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT01798004?term=ANBL12P1&rank=1

Clinical Study Identifier: TX2759

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Patricia Green

Memorial University Medical Center
Savannah, GA USA
  Connect »